There is a need to develop novel, high-throughput screening and prioritization methods to identify chemicals with adverse estrogen, androgen, and thyroid activity to protect human health and the environment and is of interest to the Endocrine Disruptor Screening Program. The current aim is to explore the utility of zebrafish as a testing paradigm to classify endocrine activity using phenotypically anchored transcriptome profiling. Transcriptome analysis was conducted on embryos exposed to 25 estrogen-, androgen-, or thyroid-active chemicals at a concentration that elicited adverse malformations or mortality at 120 hours post-fertilization in 80% of the animals exposed. Analysis of the top 1000 significant differentially expressed transcripts across all treatments identified a unique transcriptional and phenotypic profile for thyroid hormone receptor agonists, which can be used as a biomarker screen for potential thyroid hormone agonists.
Revised: March 23, 2020 |
Published: April 1, 2018
Haggard D.E., P.D. Noyes, K.M. Waters, and R. Tanguay. 2018.Transcriptomic and phenotypic profiling in developing zebrafish exposed to thyroid hormone receptor agonists.Reproductive Toxicology 77.PNNL-SA-122324.doi:10.1016/j.reprotox.2018.02.006